Cellid, Co., Ltd. (KOSDAQ:299660)

South Korea · Delayed Price · Currency is KRW

3,865.00

-10.00 (-0.26%)

Sep 1, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '15 Dec 31, 2015
E-commerce	3.81B	Log In	Log In	Log In
New Drug Development	358.05M	Log In	Log In	Log In
Immunotherapeutic Vaccines	-	Log In	Log In	Log In
Immunotherapeutic Vaccines Growth	-	Log In	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '15 Dec 31, 2015
South Korea	4.17B	Log In	Log In	Log In
South Korea Growth	767.73%	Log In	Log In	Log In